osteoporosis semaglutide A study presented at the #AAOS2026 Annual Meeting revealed GLP-1 receptor agonist use was associated with a 29% higher risk of after five years. As these medications become more widely used Penn GLP-1 study finds small

How quickly does acid reflux improve on GLP-1 medications

These are vendor and community figures for laboratory research settings, not validated human clinical doses, and this article is not dosing guidance

CrossRef An umbrella meta-analysis of microbial therapy on hepatic steatosis, fibrosis, and liver stiffness in metabolic dysfunction-associated steatotic liver disease Gvzalnur Kurban, Xiangjun Chen, Xingyi Jin, Hui Xia, Shaokang Wang, Guiju Sun Frontiers in Nutrition .2025;[Epub] CrossRef Linking bisphenol a exposure to MASLD: insights from network toxicology and machine learning based on NHANES 20052012 data Jiaquan Yuan, Haoyang Xu, Junhong Gan, Haiyan Zhao Toxicology Research .2025;[Epub] CrossRef Curcumin and Tetrahydrocurcumin as Multi-Organ Modulators of the Adipose TissueGutLiver Axis: Mechanistic Insights, Therapeutic Potential, and Translational Challenges Marina Konaktchieva, Radoslav Stojchevski, Nikola Hadzi-Petrushev, Hristo Gagov, Rositza Konakchieva, Vadim Mitrokhin, Gjoko Kungulovski, Mitko Mladenov, Dimiter Avtanski Pharmaceuticals .2025

Results from a randomized trial comparing semaglutide (2.4 mg), Liraglutide (3 mg), and matching placebo (placebo) showed that those on semaglutide lost 9.4 percent more weight from baseline when combined with diet and exercise than those on Liraglutide, according to research by Domenica M